Although PTC is the most common thyroid malignancy in both pediatric and adult populations, established molecular differences—such as the predominance of BRAFV600E and RAS mutations in adults versus RET, NTRK, ALK, and MET alterations in children—may result in cytomorphological differences [11]. The gene discussed is MET; the disease is thyroid gland disorder.